Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer

Journal of Clinical Oncology

Volumn 33, Issue 21, 2015, Pages 2370-2375

  Adam, Mohamed Abdelgadir ^a   Pura, John ^a   Goffredo, Paolo ^a   Dinan, Michaela A ^a   Reed, Shelby D ^a   Scheri, Randall P ^a   Hyslop, Terry ^a   Roman, Sanziana A ^a   Sosa, Julie A ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA; CANCER STAGING; CARCINOMA, PAPILLARY; MORTALITY; PATHOLOGY; PROGNOSIS; RISK FACTOR; SURVIVAL; THYROID NEOPLASMS;

ADULT; AGE FACTORS; CARCINOMA, PAPILLARY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SEER PROGRAM; SURVIVAL ANALYSIS; THYROID NEOPLASMS;

EID: 84940468838     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.59.8391     Document Type: Article

References (19)

1. American Cancer Society: Cancer Facts & Figures 2014. http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf
2. Siegel R, DeSantis C, Virgo K, et al: Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220-241, 2012
3. Davies L, Welch HG: Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167, 2006
4. Zaydfudim V, Feurer ID, Griffin MR, et al: The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144:1070-1077, 2008
5. Nixon IJ, Wang LY, Palmer FL, et al: The impact of nodal status on outcome in older patients with papillary thyroid cancer. Surgery 156:137-146, 2014
6. Edge S, Byrd DR, Compton CC, et al: (eds): AJCC Cancer Staging Manual (ed 7) prepared by the American Joint Committee on Cancer. New York, NY, Springer-Verlag, 2010
7. Hughes CJ, Shaha AR, Shah JP, et al: Impact of lymph node metastasis in differentiated carcinoma of the thyroid: A matched-pair analysis. Head Neck 18:127-132, 1996
8. Tran Cao HS, Johnston LE, Chang DC, et al: A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry. Surgery 152:145-151, 2012
9. Schneider DF, Chen H, Sippel RS: Impact of lymph node ratio on survival in papillary thyroid cancer. Ann Surg Oncol 20:1906-1911, 2013
10. Raval MV, Bilimoria KY, Stewart AK, et al: Using the NCDB for cancer care improvement: An introduction to available quality assessment tools. J Surg Oncol 99:488-490, 2009
11. Bilimoria KY, Bentrem DJ, Ko CY, et al: Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:375-381, 2007
12. Adam MA, Pura J, Gu L, et al: Extent of surgery for papillary thyroid cancer is not associated with survival: An analysis of 61,775 patients. Ann Surg 260:601-605, 2014
13. Hernán MA: The hazards of hazard ratios. Epidemiology 21:13-15, 2010
14. Contal C, O'Quigley J: An application of changepoint methods in studying the effect of age on survival in breast cancer. J Comput Stat Data Anal 30:253-270, 1999
15. Ricarte-Filho J, Ganly I, Rivera M, et al: Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension. Thyroid 22:575-584, 2012
16. Leboulleux S, Rubino C, Baudin E, et al: Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90:5723-5729, 2005
17. Sato N, Oyamatsu M, Koyama Y, et al: Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol 69:151-155, 1998
18. Aschebrook-Kilfoy B, Kaplan EL, Chiu BC, et al: The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States. Ann Surg Oncol 20:2746-2753, 2013
19. Seshasai SR, Wijesuriya S, Sivakumaran R, et al: Effect of aspirin on vascular and nonvascular outcomes: Meta-analysis of randomized controlled trials. Arch Intern Med 172:209-216, 2012